Roche, Chugai PNH candidate well tolerated in Phase I/II

Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) said SKY59 (RG6107; RO7112689) was well tolerated with no treatment-related serious

Read the full 168 word article

User Sign In